The last two months have been a whirlwind of lessons learned, and learned again. COVID-19 has been a formidable opponent…both quick AND unpredictable. Healthcare is learning the hard way that a fragile supply chain is more than just an annoyance, it’s deadly. Value Analysis staff have worked around the clock to assist procurement teams in validating products, only to find that they’ve been sold to another bidder before the money transfer could be approved. Fraudulent claims and falsified documents have been provided, and internet videos of manufacturing plants seem vaguely familiar despite being from different countries. Desperate times lead to hasty decisions, and those without strong value analysis support have been disappointed by the products provided, or those never received.
